Department of Oncological Sciences, Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Cold Spring Harb Perspect Med. 2020 Aug 3;10(8):a036129. doi: 10.1101/cshperspect.a036129.
PTEN (phosphatase and tensin homolog on chromosome 10) was discovered over 20 years ago in 1997 and linked to the phosphatidylinositol 3-kinase (PI3K) and AKT oncogenes the following year. The discovery of PTEN emerged from the linked concepts of oncogenes and tumor suppressor genes that cause and prevent cancer and the fields of tumor viruses and human cancer genetics from which these two concepts arose. While much has been learned since, the initial discovery and characterization, including the discovery that PTEN is a regulator of PI3K and AKT, provide the foundation on which we continue to build our knowledge. To provide the context in which these cancer genes were discovered, background information that led to their discovery will also be discussed, which will hopefully be a useful guide for readers seeking to build on the work of others.
PTEN(第 10 号染色体磷酸酶及张力蛋白同源物)于 20 多年前的 1997 年被发现,并于次年与磷脂酰肌醇 3-激酶(PI3K)和 AKT 癌基因相关联。PTEN 的发现源于致癌基因和肿瘤抑制基因的概念,这些概念导致并预防癌症,以及肿瘤病毒和人类癌症遗传学这两个概念出现的领域。尽管此后已经有了很多了解,但最初的发现和特征描述,包括发现 PTEN 是 PI3K 和 AKT 的调节剂,为我们继续建立知识提供了基础。为了提供发现这些癌症基因的背景,还将讨论导致它们被发现的背景信息,希望这对寻求在他人工作基础上有所建树的读者有所帮助。